Navigation Links
DrugRisks Adds New Pradaxa Study Alert As Lawsuits Increase
Date:3/28/2013

New York, NY (PRWEB) March 28, 2013

The medication safety advocates at DrugRisks.com are announcing updated information on the site for patients taking the blood thinner Pradaxa. Researchers presented the American College of Cardiology with a new study this month warning of Pradaxa bleeding risks***, as the number of injury claims continues to grow****.

DrugRisks was designed to reduce the danger of side effects from popular prescription drugs by providing patients with the latest warnings, recalls, studies and legal news. Visitors can determine if others are experiencing similar side effects and decide whether they need legal advice.

Information on the resource site shows health experts have disagreed about whether those taking Pradaxa to prevent strokes in atrial fibrillation face higher risks for internal bleeding. The FDA has updated its information to state the drug is as safe as warfarin*.

However, the Institute for Safe Medication Practices recently ranked blood thinners like Pradaxa among the most dangerous drugs available. They also cautioned that patients with bleeding from Pradaxa were nearly 5 times as likely to die than those with bleeding from warfarin**.

Now, DrugRisks has added information showing researchers from the University of Illinois at Chicago presented a study to the American College of Cardiology this month warning that the data used by the FDA may be flawed, and the risk for bleeding from Pradaxa may be higher than previously thought***.

Due to the number of patients who have filed a Pradaxa lawsuit over allegations of internal bleeding, cases have been consolidated to a special federal court in Illinois. The case is formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

DrugRisks has also reviewed the latest information from the federal judicial panel on multidistrict litigation, which shows the number of lawsuits alleging serious or fatal internal bleeding has grown from 170 on January 14th to 260 as of March 5, 2013, an increase of over 50%.****

Those affected by internal bleeding after taking Pradaxa are encouraged to speak with a lawyer about their legal options. Since federal drug injury cases can be very specialized, DrugRisks only recommends lawyers who have already handled Pradaxa lawsuits.

Visit http://www.DrugRisks.com for more information on the research, Pradaxa side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer.

*fda.gov/Drugs/DrugSafety/ucm326580.htm
**Instutute for Safe Medication Practices, 1/9/13; ismp.org/quarterwatch/pdfs/2012Q2.pdf
***http://www.dailyrx.com/dabigatran-prevent-stroke-and-blood-clots-may-cause-excess-bleeding-reports-are-conflicting
****jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_by_District-March-5-2013.pdf

Read the full story at http://www.prweb.com/releases/pradaxa-side-effects/litigation-lawsuit/prweb10579374.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisks Adds Update from First Actos Trial of Patient Alleging Bladder Cancer
2. Approval of Safer Alternative to Pradaxa Delayed by FDA
3. Pradaxa Maker Working on Antidote Amid Pradaxa Bleeding Warnings
4. FDA: Dont Use Pradaxa Blood Thinner in Patients With Artificial Heart Valves
5. Pradaxa Side Effect Warning: Pradaxa Label to Warn Blood-Thinner Shouldn’t be Used in People with Mechanical Heart Valves, Bernstein Liebhard LLP Reports
6. Carey Danis & Lowe Issues an Update on the Pradaxa Multi-District Litigation No. 2385
7. Pradaxa Lawsuits Being Investigated by Bernstein Liebhard LLP, as Next Conference in Federal Pradaxa Litigation Set for January 10th
8. DrugRisk Announces New Pradaxa Health Warning From Australia
9. 176 Pradaxa Lawsuits Now Pending in Federal Litigation, Discovery Well Underway, Bernstein Liebhard LLP Reports
10. Pradaxa Side Effect Problems Continue, as New Report Finds Pradaxa Bleeding More Likely to Result in Death, Bernstein Liebhard LLP Reports
11. Bernstein Liebhard LLP Launches Pradaxa Lawsuit Website Providing Information on Mounting Pradaxa Litigation, Side Effects
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... , ... January 20, 2017 , ... Michael and Betsy ... Farber Cancer Institute. For Betsy, the clinical trial has been life-saving as she ... not worsened. , Betsy Brauser was diagnosed with ovarian cancer in 2009. She ...
(Date:1/20/2017)... ... ... “Mary Magdalene: Grace is Greater than Sin”: a unique and memorable piece ... “Mary Magdalene: Grace is Greater than Sin” is the creation of published author, Brenda ... women who had little knowledge of the female characters portrayed in the Holy Bible. ...
(Date:1/20/2017)... ... , ... “I Forgive You”: a fine examination of how God handles sin, including how ... published author, Stephen Miller, who, for over ten long years has been waiting to release ... Trinidad and Tobago, he has been serving the Lord for over twenty years, and he ...
(Date:1/20/2017)... ... ... enchanting tale that teaches children the true meaning of Christmas. “Journey to Christmas” is the ... devoted woman of faith. , “Becoming a parent changes you. In my case, the ... years, but actually doing it might have been a while in coming if it hadn’t ...
(Date:1/20/2017)... ... 2017 , ... “God's Miracle Man: Against All Odds”: an inspiring affirmation ... author, Keith C. A. Tucker, son of Minister Delores Pinnock and a Jamaican native ... Mark Hardy , “While sitting up in bed, I felt a pounding headache. It ...
Breaking Medicine News(10 mins):
(Date:1/20/2017)... , January 20, 2017 Stock-Callers.com today ... SGYP ), Novo Nordisk A/S (NYSE: ... and Pernix Therapeutics Holdings Inc. (NASDAQ: PTX ). ... Thursday, January 19 th , 2017, finishing near its session ... Index dropped over 0.7%, while shares of health care companies ...
(Date:1/20/2017)... LONDON , January 20, 2017 Avillion ... the appointment of Mark Weinberg , MD MBA as Chief ... , USA . ... Dr Weinberg has spent more than 17 ... "top 20" pharma companies to micro-cap biotech. Over the course of ...
(Date:1/19/2017)... -- The U.S. Food and Drug Administration today approved Trulance ... adult patients. "No one medication works for ... Beitz , M.D., director of the Office of Drug Evaluation ... "With the availability of new therapies, patients and their doctors ... ...
Breaking Medicine Technology: